Evidence of microgliosis in the brain of human GRN mutation carriers and animal models of GRN-FTD18–20,52, to a greater degree than in sporadic and other mutation-driven FTD cases39–42, points to microglia as a key pathologic factor in GRN-FTD. Here, GRN is linked to frontotemporal dementia.